GSTC GSTC

Globestar Therapeutics (PK) Stock Price

0.0162
-0.00065 (-3.86%)
0.0162
Volume 25,244,160
Bid Price 0.0156
Ask Price 0.017
News -
Day High 0.0214

Low
0.0025

52 Week Range

High
0.0214

Day Low 0.0152
Company Name Stock Ticker Symbol Market Type
Globestar Therapeutics Corporation (PK) GSTC OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.00065 -3.86% 0.0162 16:00:59
Open Price Low Price High Price Close Price Prev Close
0.0161 0.0152 0.0214 0.0162 0.01685
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
642 25,244,160 $ 0.018781 $ 474,113 - 0.0025 - 0.0214
Last Trade Time Type Quantity Stock Price Currency
15:59:51 69,880 $ 0.0162 USD

Period:

Draw Mode:

Globestar Therapeutics Corporation (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 12.48M 770.36M 446.54M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
15.00k $ - - - -

more financials information »

Globestar Therapeutics (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical GSTC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.01760.02140.01030.016029322,280,171-0.0014-7.95%
1 Month0.00350.02140.00330.0111517,051,0330.0127362.86%
3 Months0.00360.02140.00250.00930567,379,1280.0126350.0%
6 Months0.0040.02140.00250.0068845,907,2120.0122305.0%
1 Year0.01260.02140.00250.00714694,118,2360.003628.57%
3 Years0.0730.0730.00250.0114583,494,818-0.0568-77.81%
5 Years0.049250.104350.00250.01421053,501,842-0.03305-67.11%

Globestar Therapeutics (PK) Description

GlobeStar Therapeutics Corporation ("GlobeStar"), headquartered in Richland, Washington, was incorporated in 2016 and owns breakthrough addition of treatment for Multiple Sclerosis and other neurodegenerative diseases as well other pharmaceuticals and nutraceutical. GlobeStar is a clinical stage pharmaceutical company testing a worldwide patented formulation of 3 drugs previously approved by the FDA. Pre-clinical trials in Italy showed the drug combination was effective in the reduction of MS co-morbidities. GlobeStar is initiating discussions with the FDA on clinical trial design in the U.S. in preparation for FDA submission and approval.